Oral microbiome in Proliferative Verrucous Leukoplakia exhibits loss of diversity and enrichment of pathogens

Objectives: Oral microbiome plays an important role in oral diseases. Among them, proliferative verrucous leucoplakia (PVL) is an uncommon form of progressive multifocal leukoplakia with a worryingly rate of malignant transformation. Here, we aimed to characterize the oral microbiome of PVL patients...

Full description

Bibliographic Details
Main Authors: Bagan, J. (Author), Bagan, L. (Author), Gallach, S. (Author), Herreros-Pomares, A. (Author), Jantus-Lewintre, E. (Author), Llorens, C. (Author), Murillo, J. (Author), Soriano, B. (Author), Zhang, F. (Author)
Format: Article
Language:English
Published: Elsevier Ltd 2021
Subjects:
DNA
Online Access:View Fulltext in Publisher
LEADER 04893nam a2201225Ia 4500
001 10.1016-j.oraloncology.2021.105404
008 220427s2021 CNT 000 0 und d
020 |a 13688375 (ISSN) 
245 1 0 |a Oral microbiome in Proliferative Verrucous Leukoplakia exhibits loss of diversity and enrichment of pathogens 
260 0 |b Elsevier Ltd  |c 2021 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1016/j.oraloncology.2021.105404 
520 3 |a Objectives: Oral microbiome plays an important role in oral diseases. Among them, proliferative verrucous leucoplakia (PVL) is an uncommon form of progressive multifocal leukoplakia with a worryingly rate of malignant transformation. Here, we aimed to characterize the oral microbiome of PVL patients and compare it with those of healthy controls. Material and methods: Oral biopsies from ten PVL patients and five healthy individuals were obtained and used to compare their microbial communities. The sequence of the V3-V4 region of 16S rRNA gene was used as the taxonomic basis to estimate and analyze the composition and diversity of bacterial populations present in the samples. Results: Our results show that the oral microbial composition and diversity are significantly different among PVL patients and healthy donors. The average number of observed operational taxonomic units (OTUs) was higher for healthy donors than for PVL, proving a loss of diversity in PVL. Several OTUs were found to be more abundant in either group. Among those that were significantly enriched in PVL patients, potential protumorigenic pathogens like Oribacterium sp. oral taxon 108, Campylobacter jejuni, uncultured Eubacterium sp., Tannerella, and Porphyromonas were identified. Conclusion: Oral microbiome dysbiosis was found in patients suffering from PVL. To the best of our knowledge, this is the first study investigating the oral microbiome alterations in PVL and, due to the limited number of participants, additional studies are needed. Oral microbiota-based biomarkers may be helpful in predicting the risks for the development of PVL. © 2021 The Authors 
650 0 4 |a 16S rRNA 
650 0 4 |a Actinobacteria 
650 0 4 |a adult 
650 0 4 |a aged 
650 0 4 |a Aggregatibacter 
650 0 4 |a Article 
650 0 4 |a Bacillus 
650 0 4 |a bacterium identification 
650 0 4 |a Bacteroidales 
650 0 4 |a Bacteroidetes 
650 0 4 |a biopsy 
650 0 4 |a Biopsy 
650 0 4 |a buccal mucosa 
650 0 4 |a Campylobacter 
650 0 4 |a Campylobacter 
650 0 4 |a Campylobacter jejuni 
650 0 4 |a cell transformation 
650 0 4 |a Cell Transformation, Neoplastic 
650 0 4 |a clinical article 
650 0 4 |a cohort analysis 
650 0 4 |a community structure 
650 0 4 |a comparative study 
650 0 4 |a controlled study 
650 0 4 |a Corynebacterium 
650 0 4 |a DNA 
650 0 4 |a dysplasia 
650 0 4 |a Eubacterium 
650 0 4 |a Eubacterium 
650 0 4 |a Exiguobacterium 
650 0 4 |a female 
650 0 4 |a Firmicutes 
650 0 4 |a Fusobacteria 
650 0 4 |a Fusobacterium 
650 0 4 |a genetics 
650 0 4 |a gingiva 
650 0 4 |a Granulicatella 
650 0 4 |a Haemophilus 
650 0 4 |a Head and neck cancer 
650 0 4 |a human 
650 0 4 |a human tissue 
650 0 4 |a Humans 
650 0 4 |a illumina sequencing 
650 0 4 |a infectious agent 
650 0 4 |a Leptotrichia 
650 0 4 |a leukoplakia 
650 0 4 |a leukoplakia 
650 0 4 |a Leukoplakia, Oral 
650 0 4 |a male 
650 0 4 |a microbial community 
650 0 4 |a microbial diversity 
650 0 4 |a microbiology 
650 0 4 |a Microbiota 
650 0 4 |a Microbiota 
650 0 4 |a microflora 
650 0 4 |a Mobiluncus 
650 0 4 |a mouth 
650 0 4 |a Mouth 
650 0 4 |a mouth flora 
650 0 4 |a mucosa 
650 0 4 |a Mycoplasma 
650 0 4 |a oral biopsy 
650 0 4 |a Oral cancer 
650 0 4 |a Oral leukoplakia 
650 0 4 |a Oribacterium 
650 0 4 |a Pathogens 
650 0 4 |a Peptoniphilus 
650 0 4 |a Porphyromonas 
650 0 4 |a Porphyromonas 
650 0 4 |a proliferative verrucous leukoplakia 
650 0 4 |a Proteobacteria 
650 0 4 |a real time polymerase chain reaction 
650 0 4 |a ribosome RNA 
650 0 4 |a RNA 16S 
650 0 4 |a RNA 16S 
650 0 4 |a RNA, Ribosomal, 16S 
650 0 4 |a Rothia 
650 0 4 |a Streptococcus 
650 0 4 |a Streptococcus agalactiae 
650 0 4 |a Tannerella 
650 0 4 |a taxon 
650 0 4 |a taxonomy 
650 0 4 |a Veillonella 
650 0 4 |a very elderly 
700 1 |a Bagan, J.  |e author 
700 1 |a Bagan, L.  |e author 
700 1 |a Gallach, S.  |e author 
700 1 |a Herreros-Pomares, A.  |e author 
700 1 |a Jantus-Lewintre, E.  |e author 
700 1 |a Llorens, C.  |e author 
700 1 |a Murillo, J.  |e author 
700 1 |a Soriano, B.  |e author 
700 1 |a Zhang, F.  |e author 
773 |t Oral Oncology